Bradner James E.

SEC CIK 2005159 · EDGAR

Companies

Ticker	Company	Title	Holding	Bought	Sold	Trades	First	Last
AMGN	Amgen	EVP, Research, Development	30.0K	—	—	7	2024-02-09	2026-05-07

Most active insiders at AMGN, 12 months

#	Insider	Title	Bought	Sold
1	Santos Esteban	EVP, Ops	—	$20.77M
2	Grygiel Nancy A.	SVP, CCO	—	$2.65M
3	Gordon Murdo	EVP, Gbl Commercial Ops	—	$2.32M
4	Khosla Rachna	SVP, Business Development	—	$1.65M
5	Miller Derek	SVP, Human Resources	—	$1.57M
6	Busch Matthew C.	VP, CAO, Fin	—	$375.8K
7	Klotman Mary E.	Dir	—	—
8	Bradner James E.	EVP, Research, Development	—	—
9	Drake Michael V	Dir	—	—
10	Griffith Peter H.	EVP, CFO	—	—

Transactions 7

X	Filed	Traded	Ticker	Company	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2026-05-11 19:36	2026-05-07	AMGN	Amgen	Bradner James E.	EVP, Research, Development	F - Tax	$331.11	-446	30.0K	-1%	-$147.7K
D	2026-05-07 21:14	2026-05-05	AMGN	Amgen	Bradner James E.	EVP, Research, Development	A - Grant	$0.00	+3,337	30.9K	+12%	$0
D	2026-05-07 21:14	2026-05-06	AMGN	Amgen	Bradner James E.	EVP, Research, Development	F - Tax	$329.59	-407	30.5K	-1%	-$134.1K
M	2026-02-10	2026-02-09	AMGN	Amgen	Bradner James E.	EVP, Research, Development	F - Tax	$384.32	-3,104	28.3K	-10%	-$1.19M
D	2025-05-08	2025-05-06	AMGN	Amgen	Bradner James E.	EVP, R, D, Chief Sci. Off	A - Grant	$0.00	+3,549	29.8K	+14%	$0
D	2024-05-09	2024-05-07	AMGN	Amgen	Bradner James E.	EVP, R, D, Chief Sci. Off	A - Grant	$0.00	+2,863	25.4K	+13%	$0
M	2024-02-12	2024-02-09	AMGN	Amgen	Bradner James E.	EVP, R, D, Chief Sci. Off	A - Grant	$0.00	+22.4K	22.4K	New	$0

Purchase Sale Sale after option exercise All abbreviations